MGC Diagnostics

In the Know: Healthcare News for June 29, 2020

preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator with BrainSense™ Technology Minnesota business groups oppose visa suspensions for foreign workers Blue Cross first MN health plan with role for expert guidance for gender care Cryosa Raises $8.25M in Fresh Financing Round 20 medical […]

FDA Authorizes First-Of-Its-Kind Low-Cost Ventilator Developed by University of Minnesota

Via University of Minnesota The U.S. Food and Drug Administration (FDA) today authorized the production and use of a low-cost ventilator first conceived by a team of University of Minnesota researchers and an alumnus. Known as the Coventor, this ventilator is the first-of-its-kind authorized for use under the FDA’s Emergency Use Authorization for the COVID-19 outbreak.  “Our […]

In the Know: Healthcare News from Medical Alley, March 1, 2019

Tiny medical device designed in Minnesota repairs the tiniest hearts StemoniX lands $14.4M to develop ‘micro-organs’ – Minneapolis / St. Paul Business Journal Medtronic’s RF Ablation Platform FDA Cleared to Control Pain Mayo Clinic researchers identify gene that may predict pancreatic cancer in people with Type 2 diabetes Microbiologics rapidly evolving in the virology industry […]

For The Record with MGC Diagnostics CEO, Todd Austin

Will the future of healthcare be most significantly defined by reigning in costs or accelerating outcomes? I believe it will be a combination of both. The cost of providing healthcare, whether diagnostic, therapeutic or pharmacologic, will always be under pressure, thus manufactures will be continuously reducing cost of goods sold to maintain gross margin. Healthcare […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER